SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Olsen BR, Reginato AM, Wang W 2000 Bone development. Annu Rev Cell Dev Biol 16: 191220.
  • 2
    Mundlos S, Olsen BR 1997 Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J 11: 125132.
  • 3
    Karsenty G 2003 The complexities of skeletal biology. Nature 423: 316318.
  • 4
    Blair HC, Zaidi M, Schlesinger PH 2002 Mechanisms balancing skeletal matrix synthesis and degradation. Biochem J 364: 329341.
  • 5
    Karsenty G, Wagner EF 2002 Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2: 389406.
  • 6
    Lemaire V, Tobin FL, Greller LD, Cho CR, Suva LJ 2004 Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. J Theor Biol 229: 293309.
  • 7
    Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747754.
  • 8
    Wheeler JC, Shigesada K, Gergen JP, Ito Y 2000 Mechanisms of transcriptional regulation by Runt domain proteins. Semin Cell Dev Biol 11: 369375.
  • 9
    Yoshida CA, Yamamoto H, Fujita T, Furuichi T, Ito K, Inoue K, Yamana K, Zanma A, Takada K, Ito Y, Komori T 2004 Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev 18: 952963.
  • 10
    Choi JY, Pratap J, Javed A, Zaidi SK, Xing L, Balint E, Dalamangas S, Boyce B, van Wijnen AJ, Lian JB, Stein JL, Jones SN, Stein GS 2001 Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci USA 98: 86508655.
  • 11
    Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755764.
  • 12
    Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ 1997 Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765771.
  • 13
    Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B 2002 The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 1729.
  • 14
    Dacquin R, Starbuck M, Schinke T, Karsenty G 2002 Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev Dyn 224: 245251.
  • 15
    Rossert J, Eberspaecher H, de Crombrugghe B 1995 Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice. J Cell Biol 129: 14211432.
  • 16
    Braut A, Kalajzic I, Kalajzic Z, Rowe DW, Kollar EJ, Mina M 2002 Col1a1-GFP transgene expression in developing incisors. Connect Tissue Res 43: 216219.
  • 17
    Rossert JA, Chen SS, Eberspaecher H, Smith CN, de Crombrugghe B 1996 Identification of a minimal sequence of the mouse pro-alpha 1(I) collagen promoter that confers high-level osteoblast expression in transgenic mice and that binds a protein selectively present in osteoblasts. Proc Natl Acad Sci USA 93: 10271031.
  • 18
    Marijanovic I, Jiang X, Kronenberg MS, Stover ML, Erceg I, Lichtler AC, Rowe DW 2003 Dual reporter transgene driven by 2.3Col1a1 promoter is active in differentiated osteoblasts. Croat Med J 44: 412417.
  • 19
    Akiyama H, Kim JE, Nakashima K, Balmes G, Iwai N, Deng JM, Zhang Z, Martin JF, Behringer RR, Nakamura T, de Crombrugghe B 2005 Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci USA 102: 1466514670.
  • 20
    Erben RG 1997 Embedding of bone samples in methylmethacrylate: An improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem 45: 307313.
  • 21
    Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595610.
  • 22
    Somerville JM, Aspden RM, Armour KE, Armour KJ, Reid DM 2004 Growth of C57BL/6 mice and the material and mechanical properties of cortical bone from the tibia. Calcif Tissue Int 74: 469475.
  • 23
    Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89: 309319.
  • 24
    Cadet ER, Gafni RI, McCarthy EF, McCray DR, Bacher JD, Barnes KM, Baron J 2003 Mechanisms responsible for longitudinal growth of the cortex: Coalescence of trabecular bone into cortical bone. J Bone Joint Surg Am 85: 17391748.
  • 25
    Forriol F, Shapiro F 2005 Bone development: Interaction of molecular components and biophysical forces. Clin Orthop Relat Res 432: 1444.
  • 26
    Tanck E, Hannink G, Ruimerman R, Buma P, Burger EH, Huiskes R 2006 Cortical bone development under the growth plate is regulated by mechanical load transfer. J Anat 208: 7379.
  • 27
    Aubin JE, Bonnelye E 2000 Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporos Int 11: 905913.
  • 28
    Komori T 2005 Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem 95: 445453.
  • 29
    Zhang C, Cho K, Huang Y, Lyons JP, Zhou X, Sinha K, McCrea PD, de Crombrugghe B 2008 Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc Natl Acad Sci USA 105: 69366941.
  • 30
    Khosla S 2001 Minireview: The OPG/RANKL/RANK system. Endocrinology 142: 50505055.
  • 31
    Subramaniam M, Gorny G, Johnsen SA, Monroe DG, Evans GL, Fraser DG, Rickard DJ, Rasmussen K, van Deursen JM, Turner RT, Oursler MJ, Spelsberg TC 2005 TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. Mol Cell Biol 25: 11911199.
  • 32
    Thirunavukkarasu K, Halladay DL, Miles RR, Yang X, Galvin RJ, Chandrasekhar S, Martin TJ, Onyia JE 2000 The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function. J Biol Chem 275: 2516325172.